Literature DB >> 1374629

Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.

P Hillmen1, J M Hows, L Luzzatto.   

Abstract

We have studied three glycosylphosphatidylinositol (GPI) linked proteins on the erythrocytes of 14 patients with paroxysmal nocturnal haemoglobinuria (PNH). The pattern observed was bimodal in 12 of the patients and trimodal in two. Ten patients had a red cell population with normal CD59 antigen (membrane inhibitor of reactive lysis, MIRL), decay accelerating factor (DAF or CD55) and lymphocyte function-associated antigen (LFA-3 or CD58) and a second abnormal PNH population with absent CD59 antigen, DAF and LFA-3. The other two patients with a bimodal pattern had a red cell population with normal CD59 antigen, DAF and LFA-3 and an abnormal population with reduced, but not absent, CD59 antigen and DAF. The LFA-3 on the abnormal red cells in these two patients appeared to be only slightly reduced. The two patients with a trimodal pattern had a normal population, a population with reduced, not absent, CD59 antigen and DAF, and a population with complete absence of CD59 antigen, DAF and LFA-3. The accuracy of the Ham test in estimating the proportion of red cells with the PNH defect in the two types of PNH was assessed. The case of one patient who appeared to be 'rescued' from severe aplastic anaemia by the development of PNH is described.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374629     DOI: 10.1111/j.1365-2141.1992.tb08151.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; M Bessler; P J Mason; W M Watkins; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

2.  Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria.

Authors:  Nathaniel Mon Père; Tom Lenaerts; Jorge M Pacheco; David Dingli
Journal:  PLoS Comput Biol       Date:  2018-06-18       Impact factor: 4.475

3.  Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.

Authors:  Jamile Shammo; Ajeet Gajra; Yogesh Patel; Ioannis Tomazos; Jonathan Kish; Anita Hill; J Rafael Sierra; David Araten
Journal:  J Blood Med       Date:  2022-08-12

4.  Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Pusem Patir; Yakup Isik; Yigit Turk; Mehmet Can Ugur; Cengiz Ceylan; Gulnur Gorgun; Nihal Mete Gokmen; Guray Saydam; Fahri Sahin
Journal:  Case Rep Hematol       Date:  2015-08-11

Review 5.  The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease.

Authors:  Christopher B Toomey; David M Cauvi; Kenneth M Pollard
Journal:  Autoimmune Dis       Date:  2014-01-27

6.  Paroxysmal nocturnal hemoglobinuria: When delay in diagnosis and long therapy occurs.

Authors:  Salvatrice Mancuso; Giuseppe Sucato; Melania Carlisi; Marco Santoro; Giuseppe Tarantino; Emilio Iannitto; Mariasanta Napolitano; Sergio Siragusa
Journal:  Hematol Rep       Date:  2018-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.